Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.09.2022 | Case report

Glatiramer-acetate/interferon-beta-1a

Exacerbation of susac-syndrome

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Roskal-Walek J, et al. Manifestation of Susac syndrome during interferon beta-1a and glatiramer acetate treatment for misdiagnosed multiple sclerosis: a case report. BMC Ophthalmology 21: 1-6, No. 1, 30 Sep 2021. Available from: URL: http://doi.org/10.1186/s12886-021-02101-3 Roskal-Walek J, et al. Manifestation of Susac syndrome during interferon beta-1a and glatiramer acetate treatment for misdiagnosed multiple sclerosis: a case report. BMC Ophthalmology 21: 1-6, No. 1, 30 Sep 2021. Available from: URL: http://​doi.​org/​10.​1186/​s12886-021-02101-3
Metadaten
Titel
Glatiramer-acetate/interferon-beta-1a
Exacerbation of susac-syndrome
Publikationsdatum
01.09.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-24030-7

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Catequentinib

Case report

Phenytoin

Case report

Oxytocin

Case report

AZD-1222

Case report

Cytarabine